{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:30:47Z","timestamp":1791923447223,"version":"4.3.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>As cannabis is increasingly used as a treatment option for epilepsy, people with epilepsy (PWE) may be at higher risk of developing cannabis use disorder (CUD). This study aimed to estimate the prevalence of CUD among privately insured PWE in the United States using IQVIA\u2019s 2022 PharMetrics\u00ae Plus for Academics health plan claims database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional analysis was conducted using 2022 IQVIA PharMetrics\u00ae Plus for Academics health plan claims data containing longitudinal view of inpatient and outpatient services, prescription and office\/outpatient administered drugs, costs and detailed enrollment information. Individuals with epilepsy aged 18\u202fyears and older were included. ICD-10-CM codes were used to identify epilepsy, CUD, and comorbidity conditions including mood disorders, anxiety, tobacco use, alcohol use, migraines, and sleep apnea. The prevalence of CUD was estimated, and associations between CUD and potential predictors were examined using multivariable modified Poisson regression to calculate adjusted risk ratios (aRRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of CUDs among U.S. PWE was 1.1% based on 2022 data from an analytic sample of 63,713 unique enrollees. PWE were on average 54.3\u202f\u00b1\u202f17.2\u202fyears old and 53.6% were female. PWE with CUD were more likely to be young adult males and those 18\u201334\u202fyears old. PWE with CUD had six times more tobacco use and three times more mood disorders than those without CUD. PWE 18\u201324\u202fyears old were associated with a more than five times higher risk for CUD compared to PWE who were 65+ (aRR: 5.04, 95% CI: 3.83\u20136.65,\n                      <jats:italic>p<\/jats:italic>\n                      -value:\u202f&amp;lt;\u202f0.001). Tabacco and alcohol use were associated with 6-fold increase (aRR: 5.8, 95% CI: 4.89\u20137.06,\n                      <jats:italic>p<\/jats:italic>\n                      -value:\u202f&amp;lt;\u202f0.000) and 3-fold increase (aRR: 2.83, 95% CI: 2.21\u20133.64,\n                      <jats:italic>p<\/jats:italic>\n                      -value:\u202f&amp;lt;\u202f0.001) respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PWE with substance use and psychiatric disorders are more likely to have CUD. Given the widespread prevalence of marijuana legalization across the U.S., increased awareness and potential screening for substance use disorders needs to be considered in epilepsy clinics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1695511","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:27Z","timestamp":1764566187000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of cannabis use disorders and associated factors among privately insured adults with epilepsy"],"prefix":"10.3389","volume":"16","author":[{"given":"Katarzyna","family":"Czerniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refugio","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahiti","family":"Myneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Addy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Shegog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"437","DOI":"10.15585\/mmwr.mm6715a1","article-title":"Active epilepsy and seizure control in adults\u2014United States, 2013 and 2015","volume":"67","author":"Tian","year":"2018","journal-title":"Morb Mortal Wkly Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/WNL.0b013e31827b1ae0","article-title":"Depression in epilepsy: a systematic review and meta-analysis","volume":"80","author":"Fiest","year":"2013","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.yebeh.2018.02.016","article-title":"Correlates of stigma in adults with epilepsy: a systematic review of quantitative studies","volume":"83","author":"Baker","year":"2018","journal-title":"Epilepsy Behav"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report","volume":"49","author":"Abrams","year":"2018","journal-title":"Eur J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s40265-019-01171-4","article-title":"Pharmacological and therapeutic properties of cannabidiol for epilepsy","volume":"79","author":"Franco","year":"2019","journal-title":"Drugs"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"108442","DOI":"10.1016\/j.neuropharm.2020.108442","article-title":"Cannabidiol in the treatment of epilepsy: current evidence and perspectives for further research","volume":"185","author":"Franco","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/jnnp-2018-319780","article-title":"Cannabis use is both independently associated with and mediates worse psychosocial health in patients with epilepsy","volume":"90","author":"Wahby","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","article-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health","year":"2024"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"28746","DOI":"10.26717\/BJSTR.2021.36.005886","article-title":"Considerations for the use of medical cannabis: an overview of benefits and harms","volume":"36","author":"Shakya","year":"2021","journal-title":"Biomed J Sci Tech Res"},{"key":"ref10","year":"2025"},{"key":"ref11","year":"2020"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/ajad.12898","article-title":"Cannabis use disorder and epilepsy: a cross- National Analysis of 657\u202f072 hospitalized patients","volume":"28","author":"Patel","year":"2019","journal-title":"Am J Addict"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2136571","DOI":"10.1001\/jamanetworkopen.2021.36571","article-title":"Sociodemographic characteristics associated with and prevalence and frequency of cannabis use among adults in the US","volume":"4","author":"Jeffers","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1176\/appi.ajp.20230882","article-title":"Predictors of substance use initiation by early adolescence","volume":"181","author":"Green","year":"2024","journal-title":"Am J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e209622","DOI":"10.1212\/WNL.0000000000209622","article-title":"Psychiatric comorbidities in persons with epilepsy compared with persons without epilepsy: a systematic review and Meta-analysis","volume":"103","author":"Kwon","year":"2024","journal-title":"JAMA Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1001\/jamaneurol.2016.5042","article-title":"Association of Depression and Treated Depression with Epilepsy and seizure outcomes: a multicohort analysis","volume":"74","author":"Josephson","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1111\/epi.17022","article-title":"Comorbidities in patients with epilepsy: frequency, mechanisms and effects on long-term outcome","volume":"62","author":"Giussani","year":"2021","journal-title":"Epilepsia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"106341","DOI":"10.1016\/j.eplepsyres.2020.106341","article-title":"Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States","volume":"163","author":"Lekoubou","year":"2020","journal-title":"Epilepsy Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/epi.16547","article-title":"The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies","volume":"61","author":"Mbizvo","year":"2020","journal-title":"Epilepsia"},{"key":"ref21","year":"2024"},{"key":"ref22","year":"2025"},{"key":"ref23","year":"2024"},{"key":"ref24","article-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bdi.13176","article-title":"Distinguishing between depression in bipolar disorder and unipolar depression using magnetic resonance imaging: a systematic review","volume":"24","author":"Siegel-Ramsay","year":"2022","journal-title":"Bipolar Disord"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12888-014-0289-5","article-title":"Systematic review and assessment of validated case definitions for depression in administrative data","volume":"14","author":"Fiest","year":"2014","journal-title":"BMC Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3988\/jcn.2021.17.2.176","article-title":"Systematic literature review of psychiatric comorbidities in adults with epilepsy","volume":"17","author":"Lu","year":"2021","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/acr.24048","article-title":"Defining depression and anxiety in individuals with rheumatic diseases using administrative health databases: a systematic review","volume":"72","author":"Howren","year":"2020","journal-title":"Arthritis Care Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12911-024-02416-3","article-title":"The validity of electronic health data for measuring smoking status: a systematic review and meta-analysis","volume":"24","author":"Haque","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1472-6963-12-18","article-title":"Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jclinepi.2004.01.014","article-title":"Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity","volume":"57","author":"Kolodner","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.23889\/ijpds.v3i1.448","article-title":"Identifying cases of sleep disorders through international classification of diseases (ICD) codes in administrative data","volume":"3","author":"Jolley","year":"2018","journal-title":"Int J Popul Data Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"ref34","article-title":"Statistical Software: Release 18","year":"2023"},{"key":"ref35","first-page":"71","article-title":"Barriers to and disparities in access to health care among adults aged \u2265 18 years with epilepsy\u2014United States, 2015 and 2017","author":"Tian","year":"2022"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"107050","DOI":"10.1016\/j.yebeh.2020.107050","article-title":"Poverty, insurance, and region as predictors of epilepsy treatment among US adults","volume":"107","author":"Szaflarski","year":"2020","journal-title":"Epilepsy Behav"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"106479","DOI":"10.1016\/j.addbeh.2020.106479","article-title":"What is the prevalence and risk of cannabis use disorders among people who use cannabis? A systematic review and meta-analysis","volume":"109","author":"Leung","year":"2020","journal-title":"Addict Behav"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1525-5050(03)00111-2","article-title":"The impact of epilepsy on quality of life: a qualitative analysis","volume":"4","author":"Bishop","year":"2003","journal-title":"Epilepsy Behav"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s11606-022-07948-w","article-title":"Cannabis recreational legalization and prevalence of simultaneous cannabis and alcohol use in the United States","volume":"38","author":"Gon\u00e7alves","year":"2023","journal-title":"J Gen Intern Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/08897077.2021.1944956","article-title":"Time-trends in hospitalizations with cannabis use disorder: a 17-year US national study","volume":"43","author":"Singh","year":"2022","journal-title":"Subst Abus"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"108189","DOI":"10.1016\/j.addbeh.2024.108189","article-title":"Alcohol and cannabis co-use: probing subjective response in eliciting cross-substance craving","volume":"160","author":"McManus","year":"2025","journal-title":"Addict Behav"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/10826084.2024.2305795","article-title":"Simultaneous Cannabis and alcohol use among medical Cannabis patients","volume":"59","author":"Kritikos","year":"2024","journal-title":"Subst Use Misuse"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"107859","DOI":"10.1016\/j.addbeh.2023.107859","article-title":"Screening for cannabis use disorder among young adults: sensitivity, specificity, and item-level performance of the Cannabis use disorders identification test\u2013revised","volume":"148","author":"Coelho","year":"2024","journal-title":"Addict Behav"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1111\/add.70084","article-title":"Effectiveness and safety of psychosocial interventions for the treatment of cannabis use disorder: a systematic review and meta-analysis","volume":"120","author":"Halicka","year":"2025","journal-title":"Addiction"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1695511\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:16:27Z","timestamp":1764566187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1695511\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":44,"alternative-id":["10.3389\/fneur.2025.1695511"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1695511","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"article-number":"1695511"}}